In vitro antimicrobial activity in comparison with tonsillar tissue penetration of mezlocillin.
The aim of this study was to determine the role of mezlocillin, a new acylureidopenicillin, in otorhinolaryngology. One hundred and forty-four bacterial strains were isolated from 100 patients suffering from infections of the oropharyngeal tract. Among the isolates only 10 (6.9%) resulted in being mezlocillin-resistant by the agar diffusion method. Minimum inhibitory and minimum bactericidal concentrations were also determined. Pharmacokinetic parameters e.g., diffusion in tonsillar tissue and serum concentrations, were studied. Mean mezlocillin tonsillar levels of 3.5 micrograms/g and 1.8 micrograms/g and serum concentrations of 60.2 micrograms/ml and 10.6 micrograms/ml, 1 h and 4 h respectively after administration, were found.
D000293:Adolescent; D000328:Adult; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000382:microbiology; D002648:Child; D006190:Haemophilus / Q000187:drug effects; D006801:Humans; D007709:Klebsiella / Q000187:drug effects; D008802:Mezlocillin / Q000378:metabolism / Q000494:pharmacology*; D009960:Oropharynx / Q000382:microbiology*; D014066:Palatine Tonsil / Q000378:metabolism*; D011511:Proteus / Q000187:drug effects; D011549:Pseudomonas / Q000187:drug effects; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects
D008802:Mezlocillin